Abstract:BACKGROUND:Diabetes mellitus (DM) increases the risk of adverse maternal and neonatal outcomes, and optimization of glycemic control during pregnancy can help mitigate risks associated with diabetes. However, studies seldom focus precisely on maternal blood glucose level prior to pregnancy. We aimed to evaluate the associations between preconception blood fasting plasma glucose (FPG) level and subsequent pregnancy outcomes.METHODS AND FINDINGS:We conducted a population-based retrospective cohort study among 6,447,339 women aged 20-49 years old who participated in National Free Pre-Pregnancy Checkups Project and completed pregnancy outcomes follow-up between 2010 and 2016 in China. During the preconception health examination, serum FPG concentration was measured, and self-reported history of DM was collected. Women were classified into three groups (normal FPG group: FPG < 5.6 mmol/L and no self-reported history of DM; impaired fasting glucose [IFG]: FPG 5.6-6.9 mmol/L and no self-reported history of DM; and DM: FPG ≥ 7.0 mmol/L or self-reported history of DM). The primary outcomes were adverse pregnancy outcomes, including spontaneous abortion, preterm birth (PTB), macrosomia, small for gestational age infant (SGA), birth defect, and perinatal infant death. Logistic regression model was used to calculate odds ratio (OR) and 95% confidence interval (CI) after adjusting for confounding variables. The mean age of women was 25.24 years, 91.47% were of Han nationality, and 92.85% were from rural areas. The incidence of DM and IFG was 1.18% (76,297) and 13.15% (847,737), respectively. Only 917 (1.20%) women reported a history of DM (awareness of their DM status), of whom 37.28% (337) had an elevated preconception FPG level (≥ 5.6 mmol/L), regarded as noncontrolled DM. A total of 1,005,568 (15.60%) women had adverse pregnancy outcomes. Compared with women with normal FPG, women with IFG had higher risks of spontaneous abortion (OR 1.08; 95% CI 1.06-1.09; P < 0.001), PTB (1.02; 1.01-1.03; P < 0.001), macrosomia (1.07; 1.06-1.08; P < 0.001), SGA (1.06; 1.02-1.10; P = 0.007), and perinatal infant death (1.08; 1.03-1.12; P < 0.001); the corresponding ORs for women with DM were 1.11 (95% CI 1.07-1.15; P < 0.001), 1.17 (1.14-1.20; P < 0.001), 1.13 (1.09-1.16; P < 0.001), 1.17 (1.04-1.32; P = 0.008), and 1.59 (1.44-1.76; P < 0.001). Women with DM also had a higher risk of birth defect (OR 1.42; 95% CI 1.15-1.91; P = 0.002). Among women without self-reported history of DM, there was a positive linear association between FPG levels and spontaneous abortion, PTB, macrosomia, SGA, and perinatal infant death (P for trend <0.001, <0.001, <0.001, 0.001, <0.001). Information about hypoglycemic medication before or during pregnancy was not collected, and we cannot adjust it in the analysis, which could result in underestimation of risks. Data on 2-hour plasma glucose level and HbA1c concentration were not available, and the glycemic control status was evaluated according to FPG value in women with DM.CONCLUSIONS:Women with preconception IFG or DM had higher risk of adverse pregnancy outcomes, including spontaneous abortion, PTB, macrosomia, SGA, and perinatal infant death. Preconception glycemic control through appropriate methods is one of the most important aspects of preconception care and should not be ignored by policy makers.

Effect and Predictive Value of Blood HbA1c, FBG, 2hPBG, and FINS on the Pregnancy Outcome in Patients with Gestational Diabetes Mellitus

The Influence of HbA1c and Gestational Weight Gain on Pregnancy Outcomes in Pregnant Women with Gestational Diabetes Mellitus

Serum adipocytokines in pregnant women with different glucose metabolism status

Impact of Pre-Pregnancy Body Mass Index, Weight Gain and Blood Lipid Level During Pregnancy on Pregnancy Outcome in Patients with Gestational Diabetes Mellitus.

Impact of Family History of Diabetes on Blood Glucose, Lipid Levels and Perinatal Outcomes in Pregnant Women with Gestational Diabetes Mellitus.

Preconception Diabetes Mellitus and Adverse Pregnancy Outcomes in over 6.4 Million Women: A Population-Based Cohort Study in China

The Association Between Maternal HbA1c and Adverse Outcomes in Gestational Diabetes.

The Association of Gestational Diabetes Mellitus with Fetal Birth Weight.

Relationship Between Blood Lipid Levels of Pregnant Women with Glucose Metabolism Disorders and Perinatal Outcomes

Clinical characteristics and pregnancy outcomes of gestational diabetes mellitus women of abnormal blood glucose of 75g OGTT

Adverse effects of gestational diabetes-related risk factors on pregnancy outcomes and intervention measures

[Analysis of the Effects of Gestational Diabetes Mellitus Based on Abnormal Blood Glucose on Pregnancy Outcomes].

A Multicenter All-Inclusive Prospective Study on the Relationship Between Glycemic Control Markers and Maternal and Neonatal Outcomes in Pregnant Women

Fasting blood sugar and 1 hour postprandial blood glucose levels,lipid levels,serum insulin levels and pregnancy outcomes in pregnant women with GDM

The Utility of HbA1c for Screening Gestational Diabetes Mellitus and Its Relationship with Adverse Pregnancy Outcomes

Adverse Pregnancy Outcomes and Its Associated Factors in Gestational Diabetes Mellitus with Isolated Fasting Hyperglycemia

Pregnancy outcomes and influencing factors of gestational diabetes mellitus women with isolated fasting hyperglycemia

Analysis of the Effect of Risk Factors at Gestational Diabetes Mellitus

Application Value of Predictive Model Based on Maternal Coagulation Function and Glycolipid Metabolism Indicators in Early Diagnosis of Gestational Diabetes Mellitus

Influence of Insulin Sensitivity and Secretion on Glycated Albumin and Hemoglobin A1c in Pregnant Women with Gestational Diabetes Mellitus

Insulin sensitivity, β cell function, and adverse pregnancy outcomes in women with gestational diabetes